| Market Cap | ₹27,973Cr |
| ROE | 18.88% |
| P/E Ratio(TTM) | 38.94 |
| EPS(TTM) | 45.86 |
| P/B Ratio | 7.35 |
| Dividend Yield | 0.86% |
| Industry P/E | 33.18 |
| Book Value | 242.94 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Parent Organisation | JB Chemicals & Pharmaceuticals Limited |
| Managing Director | NA |
| NSE Symbol | JBCHEPHARM |
| FUND NAME | AUM(%) |
|---|---|
| Baroda BNP Paribas Multi Cap Fund Direct Growth | 2.26% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 | ||
| Natco Pharma | NA (0.00%) | 10.66 |